
FORNARI CARLA
- U38, Piano: 5, Stanza: 5019
Pubblicazioni
Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Dettaglio
Zamagni, G., Armocida, B., Castelpietra, G., Conti, S., Cortesi, P., Ferrara, P., et al. (2026). Il carico di malattia in Italia, dal 1990 al 2023: un’analisi regionale dal Global Burden of Disease Study 2023. EPIDEMIOLOGIA E PREVENZIONE, 50(1), 67-77 [10.19191/EP26.1.A991.020]. Dettaglio
Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Dettaglio
Fornari, C., Antonacci, S., Stoppa, S., Mantovani, L., Castaman, G., Cortesi, P. (2026). Economic Implication of Targeting Higher Trough Level with Extended Half-Life FVIII Prophylaxis. FARMECONOMIA E PERCORSI TERAPEUTICI, 27(1), 13-20 [10.7175/fe.v27i1.1604]. Dettaglio
Zamagni, G., Carreras, G., Armocida, B., Gakidou, E., Ashbaugh, C., Alicandro, G., et al. (2026). National and subnational burden of disease attributable to risk factors in Italy, 1990–2023: a systematic analysis from the Global Burden of Disease Study 2023. THE LANCET PUBLIC HEALTH, 11(5), 293-305 [10.1016/S2468-2667(26)00048-4]. Dettaglio